Suchergebnisse - "Burhenne, Jürgen"

PubPharm (529)

41

Quantification of biologically active DNA alkylation in temozolomide-exposed glioblastoma cell lines by ultra-performance liquid chromatography-tandem mass spectrometry : method development and recommendations for validation

enthalten in: ACS omega | June 23, 2023

von Fresnais, M. | Jung, I. | Klein, U. | +5

42

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC

enthalten in: Nature cancer | 7 September 2023

von Zhou, X. | An, J. | Kurilov, R. | +23

43

Influence of a short course of ritonavir used as booster in antiviral therapies against SARS-CoV-2 on the exposure of atorvastatin and rosuvastatin

enthalten in: Cardiovascular drugs and therapy | 19 December 2023

Early view

von Krohmer, E. | Rohr, B. | Stoll, F. | +10

44

Protocol of the IntenSify‐Trial : An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

enthalten in: Clinical and Translational Science | 2023

von Hohmann, N. | Sprick, M. | Pohl, M. | +19

45

Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical Trial

enthalten in: International journal of molecular sciences | 2022

von Stoll, F. | Seidel-Glätzer, A. | Burghaus, I. | +14

46

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

47

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

48

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

49

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion

enthalten in: Clinical pharmacokinetics | 2022

von Nassar, Y. | Hohmann, N. | Michelet, R. | +7

50

Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation : A Nationwide Cohort Study

enthalten in: Stroke | 2022

von Nielsen, P. | Melgaard, L. | Overvad, T. | +52